Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Case-control study of human papillomavirus and oropharyngeal cancer.
|
N Engl J Med
|
2007
|
16.39
|
2
|
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
|
J Natl Cancer Inst
|
2003
|
6.28
|
3
|
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.
|
Int J Cancer
|
2007
|
4.29
|
4
|
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.
|
Clin Chem
|
2005
|
4.18
|
5
|
Bead-based multiplex genotyping of human papillomaviruses.
|
J Clin Microbiol
|
2006
|
3.13
|
6
|
Suppression of non-specific binding in serological Luminex assays.
|
J Immunol Methods
|
2005
|
2.96
|
7
|
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.
|
J Clin Oncol
|
2013
|
2.87
|
8
|
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
|
J Natl Cancer Inst
|
2006
|
2.40
|
9
|
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.01
|
10
|
HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
|
J Virol Methods
|
2002
|
1.97
|
11
|
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
|
J Clin Microbiol
|
2008
|
1.90
|
12
|
Biomarkers of HPV in head and neck squamous cell carcinoma.
|
Cancer Res
|
2012
|
1.76
|
13
|
High-risk HPV types and head and neck cancer.
|
Int J Cancer
|
2014
|
1.56
|
14
|
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
|
Gynecol Oncol
|
2002
|
1.56
|
15
|
Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
|
Int J Epidemiol
|
2011
|
1.55
|
16
|
Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.
|
J Clin Microbiol
|
2009
|
1.55
|
17
|
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.
|
J Clin Oncol
|
2007
|
1.53
|
18
|
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination.
|
Clin Cancer Res
|
2004
|
1.51
|
19
|
Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
|
Cancer Res
|
2012
|
1.49
|
20
|
High-throughput detection and multiplex identification of cell contaminations.
|
Nucleic Acids Res
|
2009
|
1.49
|
21
|
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
|
Am J Epidemiol
|
2013
|
1.48
|
22
|
High-throughput SNP-based authentication of human cell lines.
|
Int J Cancer
|
2012
|
1.46
|
23
|
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.45
|
24
|
Seroprevalence of 34 human papillomavirus types in the German general population.
|
PLoS Pathog
|
2008
|
1.44
|
25
|
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.
|
Eur J Cancer
|
2013
|
1.42
|
26
|
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
|
Int J Cancer
|
2014
|
1.40
|
27
|
Human papillomavirus seropositivity and risks of head and neck cancer.
|
Int J Cancer
|
2007
|
1.39
|
28
|
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.
|
J Gen Virol
|
2008
|
1.35
|
29
|
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
|
Cancer Res
|
2009
|
1.33
|
30
|
Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.
|
Cancer Res
|
2010
|
1.30
|
31
|
Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.29
|
32
|
Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
|
J Natl Cancer Inst
|
2013
|
1.29
|
33
|
Helicobacter pylori multiplex serology.
|
Helicobacter
|
2009
|
1.29
|
34
|
Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease.
|
J Oncol
|
2012
|
1.27
|
35
|
Race, African ancestry, and Helicobacter pylori infection in a low-income United States population.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.26
|
36
|
Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study.
|
Cancer Res
|
2004
|
1.25
|
37
|
Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
|
Cancer Res
|
2003
|
1.24
|
38
|
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer.
|
J Pathol
|
2014
|
1.23
|
39
|
A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2007
|
1.22
|
40
|
Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues.
|
J Biol Chem
|
2001
|
1.22
|
41
|
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study.
|
BMJ
|
2010
|
1.18
|
42
|
Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.
|
J Gen Virol
|
2010
|
1.16
|
43
|
Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer.
|
Clin Cancer Res
|
2011
|
1.15
|
44
|
T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.
|
Cancer Res
|
2005
|
1.13
|
45
|
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.13
|
46
|
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.12
|
47
|
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
|
Int J Cancer
|
2010
|
1.12
|
48
|
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
|
J Virol
|
2003
|
1.12
|
49
|
Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
|
Int J Cancer
|
2009
|
1.11
|
50
|
Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients.
|
J Cancer Res Clin Oncol
|
2003
|
1.10
|
51
|
Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.
|
Cancer Res
|
2009
|
1.10
|
52
|
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
|
Int J Cancer
|
2012
|
1.10
|
53
|
Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
|
Am J Obstet Gynecol
|
2003
|
1.09
|
54
|
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.
|
J Natl Cancer Inst
|
2012
|
1.09
|
55
|
Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples.
|
Int J Cancer
|
2007
|
1.07
|
56
|
Opium: an emerging risk factor for gastric adenocarcinoma.
|
Int J Cancer
|
2013
|
1.06
|
57
|
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
|
Int J Cancer
|
2008
|
1.05
|
58
|
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
|
Cancer Res
|
2009
|
1.05
|
59
|
Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer.
|
Am J Epidemiol
|
2012
|
1.04
|
60
|
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
|
Int J Cancer
|
2007
|
1.04
|
61
|
Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.04
|
62
|
HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
|
Int J Cancer
|
2005
|
1.03
|
63
|
Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.02
|
64
|
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis.
|
J Invest Dermatol
|
2008
|
1.02
|
65
|
Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
|
Int J Cancer
|
2013
|
1.02
|
66
|
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study.
|
Infect Agent Cancer
|
2011
|
1.01
|
67
|
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.
|
J Gen Virol
|
2009
|
1.01
|
68
|
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.
|
J Clin Invest
|
2013
|
1.01
|
69
|
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
|
J Clin Microbiol
|
2013
|
1.01
|
70
|
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
|
Ann Neurol
|
2014
|
0.99
|
71
|
Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.98
|
72
|
Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.
|
J Clin Microbiol
|
2005
|
0.97
|
73
|
Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study.
|
Hepatology
|
2014
|
0.97
|
74
|
Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.
|
J Gen Virol
|
2009
|
0.97
|
75
|
Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging.
|
J Virol
|
2006
|
0.96
|
76
|
Seroepidemiology of Human Polyomaviruses in a US Population.
|
Am J Epidemiol
|
2015
|
0.96
|
77
|
Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.
|
Int J Cancer
|
2008
|
0.95
|
78
|
A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
|
Int J Cancer
|
2013
|
0.95
|
79
|
Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
|
Int J Cancer
|
2011
|
0.95
|
80
|
Prevalence of human papillomavirus types in cervical and oral cancers in central India.
|
Vaccine
|
2008
|
0.95
|
81
|
Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.94
|
82
|
Serological detection systems for identification of cows shedding bovine foamy virus via milk.
|
Virology
|
2007
|
0.94
|
83
|
Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/E6AP interaction inhibitors using AlphaScreen.
|
J Biomol Screen
|
2007
|
0.94
|
84
|
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.
|
PLoS One
|
2013
|
0.93
|
85
|
Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.93
|
86
|
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes.
|
J Pediatr
|
2011
|
0.93
|
87
|
Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
|
Int J Cancer
|
2014
|
0.92
|
88
|
Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers.
|
Int J Cancer
|
2008
|
0.92
|
89
|
Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma.
|
Cancer Prev Res (Phila)
|
2013
|
0.92
|
90
|
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.
|
Cancer Res
|
2003
|
0.92
|
91
|
Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma.
|
Int J Cancer
|
2013
|
0.91
|
92
|
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.
|
Int J Cancer
|
2012
|
0.90
|
93
|
Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
|
J Pathol
|
2004
|
0.90
|
94
|
Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.89
|
95
|
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
|
Mult Scler
|
2013
|
0.89
|
96
|
Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.
|
Int J Cancer
|
2013
|
0.89
|
97
|
Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.
|
Int J Cancer
|
2013
|
0.89
|
98
|
The HPV transcriptome in HPV16 positive cell lines.
|
Mol Cell Probes
|
2011
|
0.88
|
99
|
Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.
|
J Infect Dis
|
2013
|
0.88
|
100
|
Structures of B-lymphotropic polyomavirus VP1 in complex with oligosaccharide ligands.
|
PLoS Pathog
|
2013
|
0.88
|
101
|
Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin.
|
J Invest Dermatol
|
2013
|
0.87
|
102
|
Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
|
Virology
|
2010
|
0.87
|
103
|
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
|
BMC Infect Dis
|
2014
|
0.87
|
104
|
Circulating cytokines and gastric cancer risk.
|
Cancer Causes Control
|
2013
|
0.87
|
105
|
Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients.
|
J Med Virol
|
2012
|
0.86
|
106
|
Epigenetically mediated loss of UDP-GlcNAc 2-epimerase/ManNAc kinase expression in hyposialylated cell lines.
|
Biochem Biophys Res Commun
|
2003
|
0.86
|
107
|
Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.
|
Sex Transm Dis
|
2010
|
0.86
|
108
|
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia.
|
J Gen Virol
|
2003
|
0.86
|
109
|
Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
|
J Infect Dis
|
2010
|
0.86
|
110
|
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.85
|
111
|
C-terminal deletions of Merkel cell polyomavirus large T-antigen, a highly specific surrogate marker for virally induced malignancy.
|
Int J Cancer
|
2012
|
0.85
|
112
|
Human polyomaviruses and other human viruses in neuroendocrine tumors.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.85
|
113
|
Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
|
J Cancer Res Clin Oncol
|
2003
|
0.85
|
114
|
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.
|
Int J Cancer
|
2014
|
0.84
|
115
|
Seropositivity to Helicobacter pylori and risk of pancreatic cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.84
|
116
|
Occupational asbestos exposure is associated with pharyngeal squamous cell carcinoma in men from the greater Boston area.
|
Occup Environ Med
|
2013
|
0.84
|
117
|
Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
|
Int J Cancer
|
2006
|
0.84
|
118
|
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.
|
Head Neck
|
2013
|
0.84
|
119
|
Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin.
|
J Infect Dis
|
2012
|
0.84
|
120
|
Reply to P.E. Castle.
|
J Clin Oncol
|
2013
|
0.83
|
121
|
The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.83
|
122
|
Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands.
|
J Infect Dis
|
2013
|
0.83
|
123
|
New JC virus infection patterns by in situ polymerase chain reaction in brains of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
|
J Neurovirol
|
2004
|
0.83
|
124
|
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.
|
Vaccine
|
2006
|
0.83
|
125
|
A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors.
|
Int J Cancer
|
2009
|
0.83
|
126
|
Genome-wide association study of HPV seropositivity.
|
Hum Mol Genet
|
2011
|
0.82
|
127
|
The HPV16 transcriptome in cervical lesions of different grades.
|
Mol Cell Probes
|
2011
|
0.81
|
128
|
No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.81
|
129
|
Obesity and head and neck cancer risk and survival by human papillomavirus serology.
|
Cancer Causes Control
|
2014
|
0.81
|
130
|
Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile.
|
BMC Infect Dis
|
2014
|
0.81
|
131
|
Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men.
|
Sex Transm Dis
|
2012
|
0.81
|
132
|
Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.
|
J Invest Dermatol
|
2009
|
0.81
|
133
|
Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.
|
Int J Cancer
|
2013
|
0.80
|
134
|
Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population.
|
Cancer Prev Res (Phila)
|
2011
|
0.80
|
135
|
Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
|
Int J Cancer
|
2014
|
0.79
|
136
|
Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients.
|
Virology
|
2012
|
0.78
|
137
|
Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum.
|
J Gen Virol
|
2010
|
0.78
|
138
|
Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma.
|
Virol J
|
2013
|
0.77
|
139
|
Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.
|
J Clin Microbiol
|
2011
|
0.77
|
140
|
The seroprevalence of human papillomavirus by immune status and by ethnicity in London.
|
Infect Agent Cancer
|
2009
|
0.77
|
141
|
Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men.
|
J Infect
|
2013
|
0.77
|
142
|
A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion.
|
Virol J
|
2014
|
0.77
|
143
|
The Natural History of Human Polyomaviruses and Herpesviruses in Early Life-The Rhea Birth Cohort in Greece.
|
Am J Epidemiol
|
2016
|
0.76
|
144
|
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
|
Med Microbiol Immunol
|
2015
|
0.76
|
145
|
Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats.
|
Virology
|
2005
|
0.76
|
146
|
Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
|
Cancer Res
|
2015
|
0.76
|
147
|
Genotyping of AAV plasmid stocks: quality control in adeno-associated virus vector production.
|
J Mol Microbiol Biotechnol
|
2010
|
0.76
|
148
|
Detection and typing of cutaneous human papillomavirus types--a comparison of three different methods.
|
J Virol Methods
|
2012
|
0.76
|
149
|
Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
|
Nutr Cancer
|
2014
|
0.76
|
150
|
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK.
|
Infect Agent Cancer
|
2009
|
0.75
|
151
|
Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
|
PLoS One
|
2016
|
0.75
|
152
|
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
|
Hum Vaccin Immunother
|
2014
|
0.75
|
153
|
HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men.
|
Sex Transm Dis
|
2015
|
0.75
|